Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00983008 · ClinicalTrials.gov registry record · NA
Effect and Utilization of Protected Time Among Interns on Extended Duty-Hour Call Shifts
A NA study, sponsored by Providence Health & Services.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT00983008: Clinical Trial NA study, sponsored by Providence Health & Services.
NCT00983008 is a NA study that was terminated before completion, run by Providence Health & Services. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00983008, a NA study, was terminated before completion, sponsored by Providence Health & Services.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study will test the feasibility and effectiveness of protected time for physicians in training during 30 hour shifts in a medical intensive care unit. The primary outcome will be fatigue. Secondary outcomes include the amount slept while on call, depression, and burnout.
Interventions
- BEHAVIORAL Protected time and Dedicated time
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-09 |
| Phase | NA |
Why NCT00983008 stopped before completion
NCT00983008 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Protected time and Dedicated time is the first listed.
NCT00983008 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00983008 about?
NCT00983008 is a clinical study titled "Effect and Utilization of Protected Time Among Interns on Extended Duty-Hour Call Shifts". This study will test the feasibility and effectiveness of protected time for physicians in training during 30 hour shifts in a medical intensive care unit. The primary outcome will be fatigue. Secondary outcomes include the amount slept while on call, depression, and burnout.
What is the current status of trial NCT00983008?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2009-10. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00983008?
The interventions under investigation include: Protected time and Dedicated time (BEHAVIORAL).
Who is sponsoring clinical trial NCT00983008?
This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00983008's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia